1Shrinizu A, Horikoshi S, Rinnno H, et al. Cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy[J]. J Clint Lab Anal,2003 ;17(2) :164-71.
5Coll E, Botey A, Alvarez L, et al. Serum cystatin C as new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J].Am J Kidney D ,2000 ;36( 1 ) :29-32.
6Tsutamoto T, Wada A, Sakai H, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure[J]. J Am Coll Cardio,2006 ;47(3 ) :582-6.
5CHOBANIAN A V, BAKRIS G L, BLACK H R, et al. The Seventh Report of the Joint National Committee on Prevention , Evaluation ,and Treatment of High Blood Pressure. The JNC7 Report[J]. JAMA,2003,289:2 560-2 572.
6European Society of Hypertension. European Society of Cardiology guidelines for the mangement of arterial hypertension[J ]. J Hypertens,2003,21:1 011-1 053.
7VASAN R S, LANSON M G, LEIP E P. et al. Assessment of frequency of progression to hypertension in non - hypertension paticipants in ten Franingham heart study[J]. Lancet,2001,358:16 821- 16 826.
9VASSAN R S,BEISER A, SESHANDRI,et al. Residual lifetime risk for developing hypertension in middle-ageed women and men[J]. JAMA, 2002, 289:1003-1010.
10LAZZO J L, LEVY D,BLACK H R, et al. Clinical advisory statement:importance of systolic blood pressure in older Americans[J]. Hypertension,2000,35:1021 - 1024.
